UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             WASHINGTON, D.C. 20549
                                    Form 10-Q

(Mark One)

( X )    QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE
          ACT OF 1934

For the quarterly period ended:                      June 30, 2002
                                    -------------------------------

(  )     TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES
          EXCHANGE ACT

For the transition period from:                                to
                                    ------------            --------------

Commission file number:                              0-13265
                                    ----------------------------

                         UCI MEDICAL AFFILIATES, INC.
        (Exact name of small business issuer as specified in its charter)

          Delaware                               59-2225346
(State or other jurisdiction of incorporation (IRS Employer Identification No.)
         or organization)

                     4416 Forest Drive, Columbia, SC 29206
                   (Address of principal executive offices)

                                (803) 782-4278
                           (Issuer's telephone number)

          (Former name, address or fiscal year, if changed since last report)

Indicate by check mark whether the Registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the preceding 12 months (or for such shorter period that the registrant was
required to file such reports), and (2) has been subject to such filing
requirements for the past 90 days. ( X )Yes ( ) No


State the number of shares outstanding of each of the issuer's classes of common
equity, as of the latest practicable date:

       9,650,515 shares of $.05 common stock outstanding at August 1, 2002


<PAGE>


                          UCI MEDICAL AFFILIATES, INC.

                                      INDEX
<TABLE>
<S>              <C>                                                                           <C>

                                                                                                   Page
                                                                                                 Number

PART I            FINANCIAL INFORMATION

                  Item 1   Financial Statements

                           Condensed Consolidated Balance Sheets - June 30, 2002
                           and September 30, 2001                                                        3

                           Condensed Consolidated Statements of Operations for the quarters and
                           the nine months ended June 30, 2002 and June 30, 2001                         4

                           Condensed Consolidated Statements of Cash Flows for the nine months
                           ended June 30, 2002 and June 30, 2001                                         5

                           Notes to Condensed Consolidated Financial Statements                       6 -  9

                  Item 2   Management's Discussion and Analysis of Financial
                           Condition and Results of Operations                                       10 - 14

                  Item 3   Quantitative and Qualitative Disclosures about Market Risk                     15


PART II           OTHER INFORMATION

                  Items 1-6                                                                          16 - 17


SIGNATURES                                                                                                18
</TABLE>





<PAGE>


                          UCI Medical Affiliates, Inc.
                             (Debtor-In-Possession)
                      Condensed Consolidated Balance Sheets
                                   (unaudited)
<TABLE>
<S><C>                                                           <C>                      <C>
                                                                  June 30, 2002            September 30, 2001
                                                                  --------------------     ----------------------

Assets
Current assets
   Cash and cash equivalents                                               $  162,815                  $  99,429
   Accounts receivable, less allowance for doubtful accounts
       of $1,655,110 and $1,386,416                                         6,389,393                  6,296,586
   Inventory                                                                  360,560                    360,560
   Prepaid expenses and other current assets                                  552,858                    833,732
                                                                  --------------------     ----------------------
Total current assets                                                        7,465,626                  7,590,307

Property and equipment, less accumulated depreciation of
   $7,904,455 and $7,128,248                                                3,637,335                  3,977,014
Excess of cost over fair value of assets acquired, less
   accumulated amortization of $2,451,814 and $2,451,814                    3,391,942                  3,391,942
Other assets                                                                   55,174                     23,951
                                                                  --------------------     ----------------------
Total Assets                                                             $ 14,550,077               $ 14,983,214
                                                                  ====================     ======================

Liabilities and Stockholders' Equity
Current liabilities
   Book overdraft                                                            $      0                 $  733,094
   Current portion of long-term debt                                        5,014,773                  4,858,216
   Accounts payable                                                         2,658,126                  2,801,450
   Accrued salaries and payroll taxes                                       4,264,475                  3,651,068
   Other accrued liabilities                                                1,470,572                  1,790,931
                                                                  --------------------     ----------------------
Total current liabilities                                                  13,407,946                 13,834,759

Long-term debt, net of current portion                                      1,654,395                  2,352,054
                                                                  --------------------     ----------------------
Total Liabilities                                                          15,062,341                 16,186,813
                                                                  --------------------     ----------------------

Commitments and contingencies

Stockholders' Equity
   Preferred stock, par value $.01 per share:
      Authorized shares - 10,000,000; none issued                                   0                          0
   Common stock, par value $.05 per share:
      Authorized shares - 10,000,000
      Issued and outstanding- 9,650,515 and 9,650,515 shares                  482,526                    482,526
   Paid-in capital                                                         21,723,628                 21,723,628
   Accumulated deficit                                                   (22,718,418)               (23,409,753)
                                                                  --------------------     ----------------------
Total Stockholders' Equity                                                  (512,264)                (1,203,599)
                                                                  --------------------     ----------------------
Total Liabilities and Stockholders' Equity                               $ 14,550,077                $14,983,214
                                                                  ====================     ======================
</TABLE>


         The accompanying notes are an integral part of these condensed
consolidated financial statements.


<PAGE>


                          UCI Medical Affiliates, Inc.
                             (Debtor-In-Possession)
                 Condensed Consolidated Statements of Operations
                                   (unaudited)

<TABLE>
<S>                                               <C>                   <C>                 <C>                <C>
                                                       Three Months Ended June 30,             Nine Months Ended June 30,
                                                   ------------------------------------     ----------------------------------
                                                         2002                2001                2002               2001
                                                   -----------------    ---------------     ---------------    ---------------

Revenues                                                $ 9,823,464         $9,409,100        $ 28,803,478        $28,921,736
Operating costs                                           9,176,050          8,705,327          26,670,242         26,274,099
                                                   -----------------    ---------------     ---------------    ---------------
Operating margin                                            647,414            703,773           2,133,236          2,647,637

General and administrative expenses                          17,335             12,015              45,335             38,293
Realignment and other expenses                                    0                  0                   0                  0
Impairment of goodwill                                            0                  0                   0                  0
Depreciation and amortization                               255,215            391,252             776,207          1,154,606
                                                   -----------------    ---------------     ---------------    ---------------
Income (loss) from operations                               374,864            300,506           1,311,694          1,454,738

Other expense
   Interest expense, net of interest income               (225,124)          (370,593)           (620,359)        (1,166,877)
   Loss on disposal of equipment                                  0                  0                   0                  0
                                                   -----------------    ---------------     ---------------    ---------------
Other expense                                             (225,124)          (370,593)           (620,359)        (1,166,877)

Income (loss) before benefit (provision) for
   income taxes                                             149,740           (70,087)             691,335            287,861
Benefit (provision) for income taxes                              0                  0                   0                  0
                                                   -----------------    ---------------     ---------------    ---------------

Net income (loss)                                         $ 149,740         $ (70,087)           $ 691,335          $ 287,861
                                                                        ===============     ===============    ===============
                                                   =================

Basic earnings (loss) per share                            $    .02          $   (.01)            $    .07           $    .03
                                                   =================    ===============     ===============    ===============

Basic weighted average common shares
  outstanding                                             9,650,515          9,650,515           9,650,515          9,650,515
                                                   =================    ===============     ===============    ===============

Diluted earnings (loss) per share                          $    .02          $   (.01)            $    .07           $    .03
                                                   =================    ===============     ===============    ===============

Diluted weighted average common shares
  Outstanding                                             9,650,683          9,650,515           9,649,353          9,653,778
                                                   =================    ===============     ===============    ===============
</TABLE>


         The accompanying notes are an integral part of these condensed
consolidated financial statements.



<PAGE>


                          UCI Medical Affiliates, Inc.
                             (Debtor-In-Possession)
                 Condensed Consolidated Statements of Cash Flows
                                   (unaudited)

<TABLE>
<S><C><C>                                                       <C>                    <C>
                                                                       Nine Months Ended June 30,
                                                                 ----------------------------------------
                                                                       2002                  2001
                                                                 ------------------    ------------------
Operating activities:
Net income (loss)                                                       $  691,335             $ 287,861
Adjustments to reconcile net income (loss) to net
   cash provided by  (used in) operating activities:
      Provision for losses on accounts receivable                        1,267,290             1,134,449
      Depreciation and amortization                                        776,207             1,154,606
      Impairment of goodwill                                                     0                     0
Changes in operating assets and liabilities:
   Accounts receivable                                                 (1,360,097)             (243,301)
   Inventories                                                                   0                     0
   Prepaid expenses and other current assets                               280,874                91,063
   Accounts payable and accrued expenses                                   149,724           (1,344,266)
                                                                                       ------------------
                                                                 ------------------

Cash provided by operating activities                                    1,805,333             1,080,412
                                                                 ------------------    ------------------

Investing activities:
Purchases of property and equipment                                      (436,528)             (595,241)
Disposals of property and equipment                                              0                     0
Acquisitions of goodwill                                                         0                     0
(Increase) decrease in other assets                                       (31,223)                18,760
                                                                                       ------------------
                                                                 ------------------

Cash used in investing activities                                        (467,751)             (576,481)
                                                                 ------------------    ------------------

Financing activities:
Net borrowings (payments) under line-of-credit agreement                 (377,863)             (383,767)
Increase (decrease) in book overdraft                                    (733,094)               443,250
Payments on long-term debt                                               (163,239)             (671,861)
                                                                 ------------------    ------------------

Cash used in financing activities                                      (1,274,196)             (612,378)
                                                                 ------------------    ------------------

Increase (decrease) in cash and cash equivalents                            63,386             (108,447)
Cash and cash equivalents at beginning of period                            99,429               302,927
                                                                 ------------------    ------------------
                                                                 ------------------

Cash and cash equivalents at end of period                              $  162,815            $  194,480
                                                                 ==================    ==================
</TABLE>


         The accompanying notes are an integral part of these condensed
consolidated financial statements.


<PAGE>


                          UCI MEDICAL AFFILIATES, INC.
                             (Debtor-In-Possession)
              NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
                                   (unaudited)


BASIS OF PRESENTATION:

The accompanying unaudited condensed consolidated financial statements have been
prepared in accordance with generally accepted accounting principles for interim
financial information and with the instructions to Form 10-Q and Article 10 of
Regulation S-X of the Securities and Exchange Commission. Accordingly, they do
not include all of the information and footnotes required by generally accepted
accounting principles for complete financial statements. In the opinion of
management, all adjustments (consisting only of those of a normal recurring
nature) considered necessary for a fair presentation have been included.
Operating results for the three-month and nine-month periods ended June 30, 2002
are not necessarily indicative of the results that may be expected for the
fiscal year ending September 30, 2002. For further information, refer to the
audited consolidated financial statements and footnotes thereto included in the
Company's annual report on Form 10-K for the year ended September 30, 2001.

The consolidated financial statements include the accounts of UCI Medical
Affiliates, Inc. ("UCI"), UCI Medical Affiliates of South Carolina, Inc.
("UCI-SC"), UCI Medical Affiliates of Georgia, Inc. ("UCI-GA"), Doctor's Care,
P.A., Doctor's Care of Georgia, P.C., and Doctor's Care of Tennessee, P.C. (the
three together as the "P.A."). (As used herein, the term "Company" refers to
UCI, UCI-SC, UCI-GA, and the P.A., collectively.) Because of the corporate
practice of medicine laws in the states in which the Company operates, the
Company does not own medical practices but instead enters into an exclusive
long-term management services agreements with the P.A. which operate the medical
practices. Consolidation of the financial statements is required under Emerging
Issues Task Force (EITF) 97-2 as a consequence of the nominee shareholder
arrangement that exists with respect to each of the P.A.'s. In each case, the
nominee (and sole) shareholder of the P.A. has entered into an agreement with
UCI-SC or UCI-GA, as applicable, which satisfies the requirements set forth in
footnote 1 of EITF 97-2. Under the agreement, UCI-SC or UCI-GA, as applicable,
in its sole discretion, can effect a change in the nominee shareholder at any
time for a payment of $100 from the new nominee shareholder to the old nominee
shareholder, with no limits placed on the identity of any new nominee
shareholder and no adverse impact resulting to any of UCI-SC, UCI-GA or the P.A.
resulting from such change.

In addition to the nominee shareholder arrangements described above, each of
UCI-SC and UCI-GA has entered into Administrative Service Agreements with the
P.A.'s. As a consequence of the nominee shareholder arrangements and the
Administrative Service Agreements, the Company has a long-term financial
interest in the affiliated practices of the P.A.'s. Through the Administrative
Services Agreement, the Company has exclusive authority over decision making
relating to all major on-going operations. The Company establishes annual
operating and capital budgets for the P.A. and compensation guidelines for the
licensed medical professionals. The Administrative Services Agreements have an
initial term of forty years. According to EITF 97-2, the application of FASB
Statement No. 94 (Consolidation of All Majority-Owned Subsidiaries), and APB No.
16 (Business Combinations), the Company must consolidate the results of the
affiliated practices with those of the Company. All significant intercompany
accounts and transactions are eliminated in consolidation, including management
fees.

The method of computing the management fees is based on billings of the
affiliated practices less the amounts necessary to pay professional compensation
and other professional expenses. In all cases, these fees are meant to
compensate the Company for expenses incurred in providing covered services, plus
a profit. These interests are unilaterally salable and transferable by the
Company and fluctuate based upon the actual performance of the operations of the
professional corporation.

The P.A. enters into employment agreements with physicians for terms ranging
from one to five years. All employment agreements have clauses that allow for
early termination of the agreement if certain events occur such as the loss of a
medical license.

The preparation of financial statements in conformity with generally accepted
accounting principles requires management to make estimates and assumptions that
affect the reported amounts of assets and liabilities and revenues and expenses
and the disclosure of contingent assets and liabilities. Actual results could
differ from those estimates and assumptions. Significant estimates are discussed
in the footnotes, as applicable, of the Form 10-K for the year ended September
30, 2001.

The inventory of medical supplies and drugs is carried at the lower of average
cost (first in, first out) or market. The volume of supplies carried at a center
varies very little from month to month and management, therefore, does only an
annual physical inventory count and does not maintain a perpetual inventory
system.

The Company has no items of other comprehensive income; thus, comprehensive
income and net income are the same.

Segment Information

UCI adopted FASB Statement of Financial Accounting Standards No. ("SFAS") 131,
"Disclosure about Segments of an Enterprise and Related Information," in fiscal
year 1999. SFAS No. 131 requires companies to report financial and descriptive
information about their reportable operating segments, including segment profit
or loss, certain specific revenue and expense items, and segment assets, as well
as information about the revenues derived from the Company's products and
services, the countries in which the Company earns revenues and holds assets,
and major customers. This statement also requires companies that have a single
reportable segment to disclose information about products and services,
information about geographic areas, and information about major customers. This
statement requires the use of the management approach to determine the
information to be reported. The management approach is based on the way
management organizes the enterprise to assess performance and make operating
decisions regarding the allocation of resources. It is management's opinion
that, at this time, UCI has several operating segments, however, only one
reportable segment. The following discussion sets forth the required disclosures
regarding single segment information.

UCI provides nonmedical management and administrative services for a network of
36 freestanding medical centers, 34 of which are located throughout South
Carolina and two are located in Knoxville, Tennessee (29 operating as Doctor's
Care in South Carolina, one as Doctor's Care in Knoxville, Tennessee, five as
Progressive Physical Therapy Services in South Carolina, and one as Progressive
Physical Therapy Services in Knoxville, Tennessee).

Goodwill and Other Intangible Assets

In July 2001, FASB issued SFAS No. 141, "Business Combinations" ("SFAS No. 141")
and SFAS No. 142, "Goodwill and Other Intangible Assets" ("SFAS No. 142"). SFAS
No. 141 addresses the initial recognition and measurement of goodwill and other
intangible assets acquired in a business combination. SFAS No. 142 addresses the
initial recognition and measurement of intangible assets acquired outside of a
business combination, whether acquired individually or with a group of other
assets, and the accounting and reporting for goodwill and other intangibles
subsequent to their acquisition. These standards require all future business
combinations to be accounted for using the purchase method of accounting.
Goodwill will no longer be amortized but instead will be subject to impairment
tests, at least annually. UCI has elected to adopt SFAS No. 141 and SFAS No. 142
on a prospective basis as of October 1, 2001; however, certain provisions of
these new standards also apply to any acquisitions concluded subsequent to June
30, 2001. As a result of implementing these new standards, UCI discontinued the
amortization of goodwill as of September 30, 2001. The adoption of this standard
increased by an amount equal to the amortization expenses of approximately
$450,000 annually that would have otherwise been charged to earnings under
current accounting standards. Additionally, UCI's future earnings may
periodically be affected in a materially adverse manner should particular
segments of its goodwill balances become impaired pursuant to the valuation
methodology.

EARNINGS PER SHARE

The computation of basic earnings (loss) per share and diluted earnings (loss)
per share is in conformity with the provisions of Statement of Financial
Accounting Standards No. 128 (SFAS 128).


GOING CONCERN MATTERS

The accompanying financial statements have been prepared on a going concern
basis, which contemplates the realization of assets and the satisfaction of
liabilities in the normal course of business. As shown in the financial
statements, the Company has a working capital deficiency and an accumulated
deficit. Ultimately, the Company's viability as a going concern is dependent
upon its ability to continue to generate positive cash flows from operations,
maintain adequate working capital and obtain satisfactory long-term financing.

The financial statements do not include any adjustments relating to the
recoverability and classification of liabilities that might be necessary should
the Company be unable to continue as a going concern. The Company plans include
the following, although it is not possible to predict the ultimate outcome of
the Company's efforts.

The closure of the Atlanta centers, which were unprofitable, had an immediate
positive effect on the Company in the fourth quarter of fiscal year 2000 and
continued into the first, second and third quarters of fiscal year 2002. This
improvement is expected to continue into fiscal year 2002 and beyond. However,
there can be no assurances that such improvement will occur.

CHAPTER 11 BANKRUPTCY FILING

On November 2, 2001, the Company (the "Debtors") filed a voluntary petition for
reorganization under Chapter 11 of the United States Bankruptcy Code (the
"Bankruptcy Code") in the United States Bankruptcy Court for the District of
South Carolina (the "Bankruptcy Court"). The Debtors remain in possession of
their properties and assets and management of the Company continues to operate
the business of the Debtors as a debtor-in-possession. As a
debtor-in-possession, the Company is authorized to continue to operate its
businesses, but may not engage in transactions outside the ordinary course of
business without the approval, after notice and an opportunity for a hearing, of
the Bankruptcy Court. Pursuant to the automatic stay provisions of the
Bankruptcy Code, all actions to collect pre-petition indebtedness of the
Debtors, as well as most other pending litigation against the Debtors are
currently stayed. In addition, as debtor-in-possession, the Debtors have the
right, subject to the approval of the Bankruptcy Court and certain other
conditions, to assume or reject any pre-petition executory contracts or
unexpired leases.

The Bankruptcy Court has approved payment of certain pre-petition liabilities,
such as employee wages and benefits, and settlement of certain trade payable
claims. In addition, the Bankruptcy Court has allowed for the retention of legal
and financial professionals to advise in the bankruptcy proceedings.

The Company presently intends to reorganize the Company's business and
restructure the Company's liabilities through plans of reorganization filed with
the Bankruptcy Court on May 6, 2002 (the "Plan").

At June 30, 2002, liabilities subject to compromise totaled approximately $2.3
million. The Plan calls for all pre-petition liabilities to be paid at 100% of
the total amounts, except a convertible debenture totaling approximately $1.5
million, as discussed below. Accordingly, management has elected not to
reclassify the balance sheets as illustrated by SOP 90-7, "Financial Reporting
by Entities in Reorganization Under the Bankruptcy Code," because the
reclassification of the balance sheet would not be meaningful.

Had the Company not filed Chapter 11, interest expense would have been $438,000
and $1,039,000, for quarter ending June 30, 2002 and nine-month period ending
June 30, 2002, respectively.

The difference between these amounts and the interest expense recorded is
attributed to three note payables: FPA Convertible Debenture, Family Medicine
Centers of SC, and MainStreet Healthcare, all of which have stated contractual
interest. In addition, certain capital lease obligations were rejected as part
of the reorganization. All of the aforementioned are included in the Company's
reorganization plans. Family Medicine and MainStreet Healthcare are to be paid
back at 100% of principle and no interest. The Company is expecting to be
released from the FPA debt, as FPA no longer is in existence.

Under the priority scheme established by the Bankruptcy Code, certain
post-petition liabilities and pre-petition liabilities need to be satisfied
before shareholders can receive any distribution. The ultimate recovery to
shareholders, if any, will not be determined until confirmation of the plans of
reorganization. There can be no assurance as to what value, if any, will be
ascribed to the Company's common stock in the bankruptcy proceedings.

Subsequent Event

On July 29, 2002, the Plan was approved by the Bankruptcy Court at the final
confirmation hearing. As of the date hereof, an order confirming the Plan has
not been entered by the court. The Company anticipates filing within fifteen
calendar days after the date of entry of such order a Form 8-K summarizing the
material features of the Plan.



<PAGE>


                                     PART I

                              FINANCIAL INFORMATION

                                     ITEM 2


MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND
RESULTS OF OPERATIONS

The following discussion and analysis provides information which the Company
believes is relevant to an assessment and understanding of the Company's
consolidated results of operations and financial condition. This discussion
should be read in conjunction with the consolidated financial statements and
notes thereto.

The consolidated financial statements of the Company include the accounts of
UCI, UCI-SC, UCI-GA and the P.A.'s. Such consolidation is required under
Emerging Issues Task Force (EITF) 97-2 as a consequence of the nominee
shareholder arrangement that exists with respect to each of the P.A.'s. In each
case, the nominee (and sole) shareholder of the P.A. has entered into an
agreement with UCI-SC or UCI-GA, as applicable, which satisfies the requirements
set forth in footnote 1 of EITF 97-2. Under the agreement, UCI-SC or UCI-GA, as
applicable, in its sole discretion, can effect a change in the nominee
shareholder at any time for a payment of $100 from the new nominee shareholder
to the old nominee shareholder, with no limits placed on the identity of any new
nominee shareholder and no adverse impact resulting to any of UCI-SC, UCI-GA or
the P.A. resulting from such change.

In addition to the nominee shareholder arrangements described above, each of
UCI-SC and UCI-GA has entered into Administrative Service Agreements with the
P.A.'s. As a consequence of the nominee shareholder arrangements and the
Administrative Service Agreements, the Company has a long-term financial
interest in the affiliated practices of the P.A.'s. According to EITF 97-2, the
application of FASB Statement No. 94 (Consolidation of All Majority-Owned
Subsidiaries), and APB No. 16 (Business Combinations), the Company must
consolidate the results of the affiliated practices with those of the Company.

The P.A.'s enter into employment agreements with physicians for terms ranging
from one to five years. All employment agreements have clauses that allow for
early termination of the agreement if certain events occur such as the loss of a
medical license. Over 79% of the physicians employed by the P.A.'s are paid on
an hourly basis for time scheduled and worked at the medical centers. The other
physicians are salaried. Approximately 25 of the physicians have incentive
compensation arrangements; however, no amounts were accrued or paid during the
Company's three prior fiscal years that were significant. Any incentive
compensation is based upon a percentage of non-ancillary collectible charges for
services performed by a provider. Percentages range from 3% to 17% and vary by
individual employment contract. As of June 30, 2002 and 2001, the P.A.'s
employed 111 and 114 medical providers, respectively.

The net assets of the P.A.'s are not material for any period presented, and
intercompany accounts and transactions have been eliminated.

The Company does not allocate all indirect costs incurred at the corporate
offices to the Centers on a center-by-center basis. Therefore, all discussions
below are intended to be in the aggregate for the Company as a whole.

Chapter 11 Bankruptcy Filing

On November 2, 2001, the Company (the "Debtors") filed a voluntary petition for
reorganization under Chapter 11 of the United States Bankruptcy Code (the
"Bankruptcy Code") in the United States Bankruptcy Court for the District of
South Carolina (the "Bankruptcy Court"). The Debtors remain in possession of
their properties and assets, and management of the Company continues to operate
the business of the Debtors as a debtor-in-possession. As a
debtor-in-possession, the Company is authorized to continue to operate its
businesses, but may not engage in transactions outside the ordinary course of
business without the approval, after notice and an opportunity for a hearing, of
the Bankruptcy Court. Pursuant to the automatic stay provisions of the
Bankruptcy Code, all actions to collect pre-petition indebtedness of the
Debtors, as well as most other pending litigation against the Debtors are
currently stayed. In addition, as debtor-in-possession, the Debtors have the
right, subject to the approval of the Bankruptcy Court and certain other
conditions, to assume or reject any pre-petition executory contracts or
unexpired leases.

The Bankruptcy Court has approved payment of certain pre-petition liabilities,
such as employee wages and benefits, and settlement of certain trade payable
claims. In addition, the Bankruptcy Court has allowed for the retention of legal
and financial professionals to advise in the bankruptcy proceedings.

The Company presently intends to reorganize the Company's business and
restructure the Company's liabilities through the Plan filed with the Bankruptcy
Court on May 6, 2002.

Under the priority scheme established by the Bankruptcy Code, certain
post-petition liabilities and pre-petition liabilities need to be satisfied
before shareholders can receive any distribution. The ultimate recovery to
shareholders, if any, will not be determined until confirmation of a plan of
reorganization. There can be no assurance as to what value, if any, will be
ascribed to the Company's common stock in the bankruptcy proceedings.

Results of Operations
For the Three Months Ended June 30, 2002 as Compared to the Three Months
Ended June 30, 2001


UCI provides nonmedical management and administrative services for a network of
36 freestanding medical centers (the "Centers"), 34 of which are located
throughout South Carolina and two are located in Knoxville, Tennessee (29
operating as Doctor's Care in South Carolina, one as Doctor's Care in Knoxville,
Tennessee, five as Progressive Physical Therapy Services in South Carolina and
one as Progressive Physical Therapy Services in Knoxville, Tennessee).

Revenues of $9,823,000 for the quarter ended June 30, 2002 reflect an increase
of $414,000 or 4% from those of the quarter ended June 30, 2001. The Company
experienced positive trends in both patient visits and charges per patient in
both April and May of 2002 which it attributes to the continuing marketing
efforts of the Company and to the general medical condition of the populations
served during these months.

During the past three fiscal years, the Company has continued its services
provided to members of HMOs. In these arrangements, the Company, through the
P.A., acts as the designated primary caregiver for members of HMOs who have
selected one of the Company's centers or providers as their primary care
provider. In fiscal year 1994, the Company began participating in an HMO
operated by Companion HealthCare Corporation ("CHC"), a wholly owned subsidiary
of Blue Cross Blue Shield of South Carolina ("BCBS"). BCBS, through CHC, is a
primary stockholder of UCI. Including its arrangement with CHC, the Company now
participates in four HMOs and is the primary care "gatekeeper" for more than
14,000 lives at June 30, 2002. As of June 30, 2002, all of these HMOs use a
discounted fee-for-service basis for payment. HMOs do not, at this time, have a
significant penetration into the South Carolina market. The Company is not
certain if there will be growth in the market share of HMOs in the areas in
which it operates clinics.

Sustained revenues in the South Carolina and Tennessee centers in fiscal years
2002 and 2001 also reflect the Company's heightened focus on occupational
medicine and industrial health services (these revenues are referred to as
"employer paid" on the table below). Focused marketing materials, including
quarterly newsletters for employers, were developed to spotlight the Company's
services for industry. Approximately 21% of the Company's total revenues were
derived from these occupational medicine services in both 2002 and 2001.

The following table breaks out the Company's revenue and patient visits by
revenue source for the third quarter of fiscal years 2002 and 2001.

<TABLE>
<S>     <C>                                                 <C>           <C>           <C>          <C>
                                                                  Percent of                  Percent of
                             Payor                              Patient Visits                 Revenue
        ------------------------------------------------    ------------------------    -----------------------
                                                               2002         2001           2002        2001
                                                            ------------ -----------    ------------ ----------
                                                                17           17             18          18
        Patient Pay
                                                                12           12              6           7
        Employer Paid
                                                                10           10             10          10
        HMO
                                                                12           12             16          17
        Workers Compensation
                                                                 9           8               6           7
        Medicare/Medicaid
                                                                36           38             39          37
        Managed Care Insurance
                                                                 4           3               5           4
        Other (Commercial Indemnity, Champus, etc.)
</TABLE>

An operating margin of $647,000 was earned during the third quarter of fiscal
2002 as compared to an operating margin of $704,000 for the third quarter of
fiscal 2001.

Depreciation and amortization expense decreased to $255,000 in the third quarter
of fiscal 2002, down from $391,000 in the third quarter of fiscal 2001. This
decrease reflects the adoption of SFAS No. 142, "Goodwill and Other Intangible
Assets" effective October 1, 2001 and the elimination of the amortization of
goodwill. Interest expense decreased from $371,000 in the third quarter of
fiscal 2001 to $225,000 in the third quarter of fiscal 2002 primarily as a
result of a reduction in long-term debt due to regularly scheduled principal
payments and as a result of the reduction in interest rates over the past
months. In addition, certain capital lease obligations were rejected and
interest on certain notes was suspended as part of the reorganization. The
improvement in cash flow has also resulted in a reduction in bank fees.

Income tax expense is zero due to the utilization of NOL's accumulated in prior
years.

Going Concern Matters

The accompanying financial statements have been prepared on a going concern
basis, which contemplates the realization of assets and the satisfaction of
liabilities in the normal course of business. As shown in the financial
statements, the Company has a working capital deficiency and an accumulated
deficit. Ultimately, the Company's viability as a going concern is dependent
upon its ability to continue to generate positive cash flows from operations,
maintain adequate working capital and obtain satisfactory long-term financing.

The financial statements do not include any adjustments relating to the
recoverability and classification of liabilities that might be necessary should
the Company be unable to continue as a going concern. The Company plans include
the following, although it is not possible to predict the ultimate outcome of
the Company's efforts.

The closure of the Atlanta centers, which were unprofitable, had an immediate
positive effect on the Company in the fourth quarter of fiscal year 2000 and
continued into the first, second and third quarters of fiscal year 2002. This
improvement is expected to continue into fiscal year 2002 and beyond. However,
there can be no assurances that such improvement will occur.

For the Nine Months Ended June 30, 2002 as Compared to the
Nine Months Ended June 30, 2001

Revenues of $28,803,000 held almost constant from the same period in fiscal year
2001. Patient encounters decreased to 329,000 for the nine months ended June 30,
2002 from 349,000 for the nine months ended June 30, 2001. The difference in the
6% decrease in patient visits and the less than 1% decrease in revenues is due
to some rate increases in the Medicare and workers compensation fee schedules.

The following table breaks out the Company's revenue and patient visits by
revenue source for the nine months ended June 30, 2002 and June 30, 2001.

<TABLE>
<S>     <C>                                                 <C>           <C>            <C>         <C>
                                                                  Percent of                  Percent of
                             Payor                              Patient Visits                 Revenue
        ------------------------------------------------    ------------------------    -----------------------
                                                               2002         2001           2002        2001
                                                            ------------ -----------    ------------ ----------
                                                                16           17             16          16
        Patient Pay
                                                                11           12              6           7
        Employer Paid
                                                                10           11             10          11
        HMO
                                                                11           9              14          15
        Workers Compensation
                                                                11           9               8           7
        Medicare/Medicaid
                                                                37           38             41          39
        Managed Care Insurance
                                                                 4           4               5           5
        Other (Commercial Indemnity, Champus, etc.)
</TABLE>

An operating margin of $2,133,000 was earned during the nine months ended June
30, 2002 as compared to an operating margin of $2,648,000 for the nine months
ended June 30, 2001. Management believes that the decline in margin was the
result of personnel and supply costs overruns that it is in the process of
reducing. However, the personnel cost increases are in part attributable to
increased cost-cutting pressures being applied by managed care insurance payors
that cover many of the Company's patients. As managed care plans attempt to cut
costs, they typically increase the administrative burden of providers such as
the Company by requiring referral approvals and by requesting hard copies of
medical records before they will pay claims. The number of patients at the
Company's Centers that are covered by a managed care plan versus a traditional
indemnity plan continues to grow. Management expects this trend to continue. The
decline is also the result of the overall slump of the economy, which has had an
effect on patient visits.

Depreciation and amortization expense decreased to $776,000 in the nine months
ended June 30, 2002, down from $1,155,000 in the nine months ended June 30,
2001. This decrease reflects the adoption of SFAS No. 142, "Goodwill and Other
Intangible Assets" effective October 1, 2001 and the elimination of the
amortization of goodwill. Interest expense decreased from $1,167,000 for the
nine months ended June 30, 2001 to $620,000 for the nine months ended June 30,
2002 primarily as a result of a reduction in long-term debt due to regularly
scheduled principal payments and as a result of the reduction in interest rates
over the past months. In addition, certain capital lease obligations were
rejected and interest on certain notes was suspended as part of the
reorganization.

Income tax expense is zero due to the utilization of NOL's accumulated in prior
years.

Financial Condition at June 30, 2002

Cash and cash equivalents increased by $63,000 during the nine months ended June
30, 2002 mainly as a result of the timing of cash payments to vendors and salary
payments.

Accounts receivable remained about constant during the nine months ended June
30, 2002.

Long-term debt decreased from $7,210,000 at September 30, 2001 to $6,669,000 at
June 30, 2002 due to regular principal pay-downs of approximately $540,000.
Management believes that it will be able to fund debt service requirements out
of cash generated through operations and does not anticipate the availability of
additional debt financing.

Liquidity and Capital Resources

The Company requires capital for working capital needs and for the retirement of
indebtedness. The Company's capital requirements and working capital needs have
been funded through a combination of external financing (primarily bank debt),
and credit extended by suppliers.

As of June 30, 2002, the Company had no material commitments for capital
expenditures and expects to continue to fund any required expenditure from
working capital. There can be no assurance that operations will continue to
provide adequate cash needed in the future.

Operating activities produced $1,805,000 of cash during the nine months ended
June 30, 2002, compared with $1,080,000 during the same period in the prior
fiscal year.

Investing activities used only $468,000 in cash during the nine months ended
June 30, 2002 to purchase needed equipment to operate existing centers and to
upfit an existing facility to house the Corporate offices.

Financing activities utilized $1,274,000 in cash during the nine-month period
primarily for debt reduction.

Advisory Note Regarding Forward-Looking Statements

Certain of the statements contained in this PART I, Item 2 (Management's
Discussion and Analysis of Financial Condition and Results of Operations) that
are not historical facts are forward-looking statements subject to the safe
harbor created by the Private Securities Litigation Reform Act of 1995. The
Company cautions readers of this Quarterly Report on Form 10-Q that such
forward-looking statements involve known and unknown risks, uncertainties and
other factors which may cause the actual results, performance or achievements of
the Company to be materially different from those expressed or implied by such
forward-looking statements. Although the Company's management believes that
their expectations of future performance are based on reasonable assumptions
within the bounds of their knowledge of their business and operations, there can
be no assurance that actual results will not differ materially from their
expectations. Factors which could cause actual results to differ from
expectations include, among other things, the difficulty in controlling the
Company's costs of providing healthcare and administering its network of
Centers; the possible negative effects from changes in reimbursement and
capitation payment levels and payment practices by insurance companies,
healthcare plans, government payors and other payment sources; the difficulty of
attracting primary care physicians; the increasing competition for patients
among healthcare providers; possible government regulations negatively impacting
the existing organizational structure of the Company; the possible negative
effects of prospective healthcare reform; the challenges and uncertainties in
the implementation of the Company's expansion and development strategy; the
dependence on key personnel; demand for our services; technological changes; the
ability to increase market share; unanticipated regulatory or judicial
proceedings; the impact on our business, as well as on the risks set forth
above, of various domestic or international military or terrorist activities or
conflicts; and other factors described in this report and in other reports filed
by the Company with the Securities and Exchange Commission.


<PAGE>



                                     ITEM 3


QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK

The Company is exposed to changes in interest rates primarily as a result of its
borrowing activities, which includes credit facilities with financial
institutions used to maintain liquidity and fund the Company's business
operations, as well as notes payable to various third parties in connection with
certain acquisitions of property and equipment. The nature and amount of the
Company's debt may vary as a result of future business requirements, market
conditions and other factors. The definitive extent of the Company's interest
rate risk is not quantifiable or predictable because of the variability of
future interest rates and business financing requirements. The Company does not
currently use derivative instruments to adjust the Company's interest rate risk
profile.

Approximately $2,200,000 of the Company's debt at June 30, 2002 was subject to
fixed interest rates and principal payments. Approximately $4,469,000 of the
Company's debt at June 30, 2002 was subject to variable interest rates. Based on
the outstanding amounts of variable rate debt at June 30, 2002, the Company's
interest expense on an annualized basis would increase approximately $45,000 for
each increase of one percent in the prime rate.

The Company does not utilize financial instruments for trading or other
speculative purposes, nor does it utilize leveraged financial instruments.



<PAGE>



                                     PART II

                                OTHER INFORMATION



Item 1            Legal Proceedings

                  The Company is not a party to any pending litigation other
                  than routine litigation incidental to the business or that
                  which is immaterial in amount of damages sought.

                  Chapter 11 Bankruptcy Filing

                  On November 2, 2001, the Company (the "Debtors") filed a
                  voluntary petition for reorganization under Chapter 11 of the
                  United States Bankruptcy Code (the "Bankruptcy Code") in the
                  United States Bankruptcy Court for the District of South
                  Carolina (the "Bankruptcy Court"). The Debtors remain in
                  possession of their properties and assets and management of
                  the Company continues to operate the business of the Debtors
                  as a debtor-in-possession. As a debtor-in-possession, the
                  Company is authorized to continue to operate its businesses,
                  but may not engage in transactions outside the ordinary course
                  of business without the approval, after notice and an
                  opportunity for a hearing, of the Bankruptcy Court. Pursuant
                  to the automatic stay provisions of the Bankruptcy Code, all
                  actions to collect pre-petition indebtedness of the Debtors,
                  as well as most other pending litigation against the Debtors
                  are currently stayed. In addition, as debtor-in-possession,
                  the Debtors have the right, subject to the approval of the
                  Bankruptcy Court and certain other conditions, to assume or
                  reject any pre-petition executory contracts or unexpired
                  leases.

                  The Bankruptcy Court has approved payment of certain
                  pre-petition liabilities, such as employee wages and benefits,
                  and settlement of certain trade payable claims. In addition,
                  the Bankruptcy Court has allowed for the retention of legal
                  and financial professionals to advise in the bankruptcy
                  proceedings.

                  The Company presently intends to reorganize the Company's
                  business and restructure the Company's liabilities through the
                  plans of reorganization filed with the Bankruptcy Court on May
                  6, 2002. In connection with the development of the plans of
                  reorganization alternatives, the Company will evaluate any and
                  all proposals to maximize the value of the Debtors. On July
                  29, 2002, the plans of reorganization were approved by the
                  Bankruptcy Court at the final confirmation hearing. As of this
                  date, an order confirming the plans of reorganization has not
                  been entered by the court.

                  Currently, it is not possible to predict with certainty the
                  length of time the Company will operate under the protection
                  of Chapter 11, the outcome of the Chapter 11 proceedings in
                  general, or the effect of the proceedings on the business of
                  the Company or on the interests of the various creditors and
                  security holders. Under the priority scheme established by the
                  Bankruptcy Code, certain post-petition liabilities and
                  pre-petition liabilities need to be satisfied before
                  shareholders can receive any distribution. The ultimate
                  recovery to shareholders, if any, will not be determined until
                  confirmation of the plans of reorganization. There can be no
                  assurance as to what value, if any, will be ascribed to the
                  Company's common stock in the bankruptcy proceedings.

Item 2            Changes in Securities

                  This item is not applicable


Item 3            Defaults upon Senior Securities

                  This item is not applicable.

Item 4            Submission of Matters to a Vote of Security Holders

                  This item is not applicable.

Item 5            Other Information

                  This item is not applicable.

Item 6            Exhibits and Reports on Form 8-K

(a)      Exhibits.
         --------

                      None.

(b)      Reports on Form 8-K.
         -------------------

                      None.



<PAGE>




                                   SIGNATURES



Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.


UCI Medical Affiliates, Inc.
         (Registrant)



/s/ M.F. McFarland, III, M.D.         /s/ Jerry F. Wells, Jr., CPA
------------------------------------  -----------------------------------
Marion F. McFarland, III, M.D.        Jerry F. Wells, Jr., CPA
President, Chief Executive Officer,   Executive Vice President of Finance,
and Chairman of the Board             Chief Financial Officer, and
                                      Principal Accounting Officer




Date:  August 7, 2002